Laurie Sehn
MD, MPH
Clinical Professor, Division of Medical Oncology
👥Biography 个人简介
Laurie Sehn is a leading clinical investigator whose work on obinutuzumab in indolent lymphoma — including the landmark GALLIUM trial — established obinutuzumab's superiority over rituximab in combination with chemotherapy for follicular and marginal zone lymphoma. Her research addresses frontline and maintenance strategies for indolent B-cell lymphomas. She serves on the ASCO and ESMO lymphoma guideline panels.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Laurie Sehn 的研究动态
Follow Laurie Sehn's research updates
留下邮箱，当我们发布与 Laurie Sehn（BC Cancer / University of British Columbia）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment